Gardner-Smith Kenneth 4

What Happened

• Kenneth Gardner‑Smith, a director of Accendra Health Inc. (ACH), was granted 31,191 restricted shares on 2026-05-14. The Form 4 reports the acquisition as an award (transaction code A) at a reported price of $0.00 (total reported value $0), indicating these shares were granted as compensation rather than purchased.

Key Details

• Transaction date: 2026-05-14; Filing date: 2026-05-18 (filed within the normal Form 4 window).
• Transaction type/code: Award (A) — restricted stock grant.
• Shares involved: 31,191 shares; reported acquisition price: $0.00; reported total value: $0.
• Shares owned after the transaction: Not specified in the provided excerpt of the filing.
• Footnote: F1 — The restricted stock vests the earlier of (i) one year from the grant date or (ii) the date of the next annual meeting that is at least 50 weeks after the grant date.

Context

• This was a compensatory restricted stock grant, not an open‑market purchase or sale. Such awards typically vest over time (see footnote) and do not necessarily indicate immediate buying or selling intent.